(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 1177.65 | 1143.37 | 1198.88 | 3.0% | -1.8% |
Total Expenses | 1002.02 | 990.58 | 1034.89 | 1.2% | -3.2% |
Profit Before Tax | 175.64 | 152.79 | 163.99 | 15.0% | 7.1% |
Tax | 46.00 | 35.19 | 44.38 | 30.7% | 3.7% |
Profit After Tax | 129.65 | 117.60 | 119.60 | 10.2% | 8.4% |
Earnings Per Share | 5.30 | 4.80 | 4.90 | 10.4% | 8.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Granules India Ltd is a company primarily engaged in the pharmaceutical industry, focusing on the manufacturing and sale of pharmaceutical products. The company is known for its presence in the production of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages. Granules India has established a reputation for its high-volume production capabilities, which support its global distribution network. While specific recent major developments for Granules India Ltd are not provided, the company operates in a dynamic industry characterized by continuous innovation and regulatory changes.
In the fourth quarter of the fiscal year 2025, Granules India Ltd reported total income of ₹1177.65 crores. This represents a quarter-over-quarter (QoQ) increase of 3.0% compared to the third quarter of fiscal year 2025, where the total income was ₹1143.37 crores. However, there was a year-over-year (YoY) decline of 1.8% compared to the fourth quarter of fiscal year 2024, when the total income was ₹1198.88 crores. This fluctuation in revenue figures indicates a slight improvement in the company’s performance on a quarterly basis but a marginal decline when compared to the previous year.
Granules India Ltd's profitability metrics for Q4FY25 indicate positive performance. The profit before tax (PBT) for the quarter stood at ₹175.64 crores, reflecting a 15.0% increase QoQ from ₹152.79 crores in Q3FY25 and a 7.1% increase YoY from ₹163.99 crores in Q4FY24. The tax expense for Q4FY25 was ₹46.00 crores, a 30.7% increase QoQ from ₹35.19 crores in Q3FY25 and a 3.7% increase YoY from ₹44.38 crores in Q4FY24. Consequently, the profit after tax (PAT) for Q4FY25 was ₹129.65 crores, marking a 10.2% QoQ increase from ₹117.60 crores in Q3FY25 and an 8.4% YoY increase from ₹119.60 crores in Q4FY24. The earnings per share (EPS) for Q4FY25 increased by 10.4% QoQ to ₹5.30 and by 8.2% YoY from ₹4.90 in Q4FY24.
During Q4FY25, Granules India Ltd recorded total expenses of ₹1002.02 crores, showing a 1.2% QoQ increase from ₹990.58 crores in Q3FY25. Compared to Q4FY24, there was a YoY decrease of 3.2% from ₹1034.89 crores. These metrics indicate a moderate increase in quarterly expenses, while also reflecting a reduction in expenses compared to the same quarter of the previous year. The company's ability to manage its expenses is crucial for maintaining and improving profitability. The interplay between revenue, expenses, and profitability highlights how Granules India Ltd navigates the financial landscape within its operational framework.